A newly released document shows that drug giant Pfizer added a secret heart attack drug to the children’s version of its Wuhan coronavirus (COVID-19) vaccine.
The Food and Drug Administration (FDA) Advisory Committee that voted 17-0 to approve the jabs for children as young as five was notified that the children’s formulation of the drug contains tromethamine (Tris), a chemical that reduces blood acidity and stabilizes people who have suffered a heart attack.
“Each dose of this formulation contains 10 ?g (micrograms) of a nucleoside-modified messenger RNA (mRNA) encoding the viral spike (S) glycoprotein of SARS-CoV-2 that is formulated in lipid particles and supplied as a frozen suspension in multiple dose vials,” the “vaccine formulation” page of the document explains.
“To provide a vaccine with an improved stability profile, the Pfizer-BioNTech COVID-19 Vaccine for use in children 5-11 years of age uses tromethamine (Tris) buffer instead of the phosphate-buffered saline (PBS) as used in the previous formulation and excludes sodium chloride and potassium chloride.”
This “new formulation,” the document further reads, must be stored at a different temperature than the adult version of the injection.
Without so much as a second thought concerning this ingredient change, the FDA granted emergency use authorization (EUA) for this new drug to be administered to children as young as five.
This FDA briefing document was titled “EUA amendment request for Pfizer COVID-19 vaccine for use in children 5 through 11 years of age,” and was given to the advisory committee prior to its vote.